Innogenetics Logo

Innogenetics NV

Company Description
Innogenetics NV is an international biotechnology company that develops and markets diagnostic products to improve therapy management and patient health. Innogenetics develops and markets a range of diagnostic assays with a focus on molecular diagnostics and multiparameter testing. Its products are sold in over 90 countries through its 6 subsidiaries and a large number of distributors. Innogenetics is a Solvay Pharmaceuticals company. Solvay Pharmaceuticals is the global pharmaceuticals sector of the Solvay Group.

Based on a solid scientific and technical expertise as well as a strong intellectual property position for each analyte, Innogenetics has developed a neurodegenerative diseases program that focuses on the creation of a panel of robust tests for the early and differential diagnosis, and patient stratification of the primary dementias, as well as treatment follow-up. The added value of biomarkers in (differential) diagnosis of dementia, ensures that Innogenetics is well-placed to be one of the leading players in the field of Alzheimer’s disease diagnosis.

Innogenetics' headquarters are in Gent, Belgium, with sales affiliates in the United States, Germany, France, Spain, and Italy. Innogenetics employs 570 people worldwide and has a market capitalization of approximately 300 million. 

Products and Services
Based on a solid scientific and technical expertise as well as a strong intellectual property position, Innogenetics has developed a neurodegenerative diseases program that focuses on the creation of a panel of robust tests for the early and differential diagnosis of the primary dementias. The added value of biomarkers in (differential) diagnosis of dementia, ensures that Innogenetics is well-placed to be one of the leading players in the field of Alzheimer's disease diagnosis.

The first products, such as INNOTEST hTAU Ag, INNOTEST -AMYLOID(1-42), INNOTEST PHOSPHO-TAU(181P), INNO-BIA AlzBio3, and INNO-LiPA ApoE are already on the market, addressing the needs of diagnostics and therapeutics research.

INNO-BIA AlzBio3 is a multiparameter bead-based immunoassay for the simultaneous measurement of beta-amyloid 1-42, total tau, and tau phosphorylated at threonine 181 in human cerebrospinal fluid (CSF) using xMAP® technology.

Contact Information
Technologiepark 6
B-9052 Gent
Belgium
Phone: +32-9-329 1329
Fax: +32-9-329 1911
www.innogenetics.com


Share: